Results 1 to 10 of about 31,333 (185)

CD30+ lymphoproliferative disorders [PDF]

Haematologica, 2010
CD30 antigen, originally identified as a cell surface marker of the malignant Hodgkin and Reed-Sternberg (HRS) cells in Hodgkin’s lymphoma by the use of the Ki-1 monoclonal antibody, is a transmembrane glycoprotein member of the tumor necrosis factor (TNF) receptor superfamily.[1][1] In ...
Laurence de Leval, Philippe Gaulard
doaj   +3 more sources

Posttransplant Lymphoproliferative Disorders [PDF]

Advances in Hematology, 2012
Posttransplant lymphoproliferative disorders (PTLDs) are a group of diseases that range from benign polyclonal to malignant monoclonal lymphoid proliferations.
Hazem A. H. Ibrahim, Kikkeri N. Naresh
doaj   +5 more sources

Immunogenetic Background of Chronic Lymphoproliferative Disorders in Romanian Patients—Case Control Study [PDF]

Medical Sciences
Background and Objectives: The implications of the genetic component in the initiation and development of chronic lymphoproliferative disorders have been the subject of intense research efforts. Some of the most important genes involved in the occurrence
Maria Tizu, Bogdan Calenic, Ion Maruntelu, Andreea Mirela Caragea, Adriana Talangescu, Larisa Ursu, Corina Rotarescu, Mariana Surugiu, Alexandra Elena Constantinescu, Ileana Constantinescu   +9 more
doaj   +2 more sources

Acquired Angioedema Associated with Lymphoproliferative Disorders [PDF]

Case Reports in Oncology
Introduction: Acquired angioedema due to C1 esterase inhibitor deficiency (C1INH-AAE) is most associated with lymphoproliferative disorders (LPDs), particularly low-grade B-cell subtypes. The condition remains under-recognized with long diagnostic delays
Jun Yen Ng, Meidelynn Ooi, Samuel K. Bennett, Kirsty Rady, Philip Choi, Wei-I. Lee, Matthew C. Cook, Katrina L. Randall, Nalini K. Pati   +8 more
doaj   +2 more sources

Posttransplantation Lymphoproliferative Disorders [PDF]

Archives of Internal Medicine, 2003
Posttransplantation lymphoproliferative disorders include a wide spectrum of diseases ranging from hyperplastic-appearing lesions to frank non-Hodgkin lymphoma. More than 90% of these disorders are Epstein-Barr virus-associated lesions of B-cell origin that arise in the setting of pharmacologic immunosuppression after transplantation.
Andreone P, Gramenzi A, Lorenzini S, Biselli M, Cursaro C, Pileri S, Bernardi M.   +6 more
openaire   +4 more sources

Activation of Interferon Signaling in Chronic Lymphocytic Leukemia Cells Contributes to Apoptosis Resistance via a JAK-Src/STAT3/Mcl-1 Signaling Pathway

Biomedicines, 2021
Besides their antiviral and immunomodulatory functions, type I (α/β) and II (γ) interferons (IFNs) exhibit either beneficial or detrimental effects on tumor progression.
Brigitte Bauvois, Elodie Pramil, Ludovic Jondreville, Claire Quiney, Florence Nguyen-Khac, Santos A. Susin   +5 more
doaj   +1 more source

“Double-Hit” Chronic Lymphocytic Leukemia, Involving the TP53 and MYC Genes

Frontiers in Oncology, 2022
Although the 17p deletion [del(17p)] is rare in cases of treatment-naive chronic lymphocytic leukemia (CLL), its frequency is higher in refractory/relapsed CLL – particularly in patients undergoing chemo(immuno)therapy.
Florence Nguyen-Khac, Florence Nguyen-Khac, Florence Nguyen-Khac   +2 more
doaj   +1 more source

KSHV/HHV8-Associated Lymphoproliferative Disorders: Lessons Learnt from People Living with HIV

Hemato, 2021
In 1992, Kaposi sarcoma herpesvirus (KSHV/HHV8) was discovered and identified as the causative agent for Kaposi sarcoma. Subsequently, the presence of this virus has been detected in a number of lymphoproliferative disorders in people living with HIV ...
Mark Bower, Antonino Carbone
doaj   +1 more source

Histopathological and Clinical Features of Methotrexate-Associated Lymphoproliferative Disorders and Post-Transplant Lymphoproliferative Disorders

Siriraj Medical Journal, 2022
Objective: To study histopathological and clinical features of methotrexate-associated lymphoproliferative disorders (MTX-LPD) and post-transplant lymphoproliferative disorders (PTLD).
Preeyawat Ngamdamrongkiat, Emvalee Arromdee, Attapong Vongwiwatana, Weerapat Owattanapanich, Sanya Sukpanichnant   +4 more
doaj   +1 more source

EBV-Associated Lymphoproliferative Disorders

Clinical Pediatric Hematology-Oncology, 2021
Epstein Barr virus (EBV) is associated with a wide range of human lymphoproliferative disorders (LPD) of B, T, and natural killer (NK)-cell lineage. In children, abnormal immune response to primary EBV infection can cause peculiar forms of T/NK- cell LPD
Young Hyeh Ko
doaj   +1 more source